SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps available in the
United States, plans to release its third quarter 2017 results after the
financial markets close on Thursday, October 26, 2017. The Company will
hold a conference call and simultaneous webcast on the same day at
4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter
2017 financial and operating results.
Conference Call/Webcast Details:
October 26, 2017
Time: 4:30pm Eastern Time (1:30pm
Toll Free Dial-In Number: (855) 427-4396
Dial-In Number: (484) 756-4261
Conference ID: 99237651
An archive of the webcast will be available for 30 days following the
event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com
in the "Events & Presentations" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump, the only pump capable of remote feature updates using
a personal computer, now available with Dexcom G5® Mobile continuous
glucose monitoring (CGM) integration, and the t:flex® Insulin Pump, the
first pump designed for people with greater insulin requirements. Tandem
is based in San Diego, California.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
t:flex and Tandem Diabetes Care are registered trademarks, and t:slim X2
is a trademark of Tandem Diabetes Care, Inc. Dexcom G5 is a registered
trademark of Dexcom, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171016006119/en/
Tandem Diabetes Care, Inc.
Susan Morrison, 858-366-6900 x7005
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media